IDXG

Interpace Biosciences, Inc. Common Stock
IDXG

Delisted

IDXG was delisted on the 24th of February, 2021.

3 hedge funds and large institutions have $58K invested in Interpace Biosciences, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
-9
Holders Change %
-75%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
1
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
HF
1
HRT Financial
New York
$52K +$52K +11,145 New
RG
2
Retirement Group
California
$5K +$5K +1,000 New
TRCT
3
Tower Research Capital (TRC)
New York
$1K -$9.9K -1,752 -91%
BlackRock
4
BlackRock
New York
-$368K -117,154 Closed
Vanguard Group
5
Vanguard Group
Pennsylvania
-$253K -80,612 Closed
Geode Capital Management
6
Geode Capital Management
Massachusetts
-$101K -32,476 Closed
Squarepoint
7
Squarepoint
New York
-$65K -20,755 Closed
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
-$40K -12,864 Closed
UBS Group
9
UBS Group
Switzerland
-$9K -2,946 Closed
AF
10
Allworth Financial
California
-$4K -1,429 Closed
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$3.14K -1,000 Closed